lind-peinture
» » Management of Early Parkinson's Disease (Oxford American Pocket Notes)

eBook Management of Early Parkinson's Disease (Oxford American Pocket Notes) ePub

by Kelly Lyons,Rajesh Pahwa

eBook Management of Early Parkinson's Disease (Oxford American Pocket Notes) ePub
Author: Kelly Lyons,Rajesh Pahwa
Language: English
ISBN: 0195386493
ISBN13: 978-0195386493
Publisher: Oxford University Press; 1 edition (January 22, 2009)
Category: Medicine
Subcategory: Medical
Rating: 4.5
Votes: 948
Formats: mobi mbr azw doc
ePub file: 1597 kb
Fb2 file: 1260 kb

by Dr. Rajesh Pahwa (Author), Dr. Kelly E. Lyons (Author). Pick up your parcel at a time and place that suits you.

by Dr.

by Rajesh Pahwa, Kelly Lyons. ISBN 9780195395617 (978-0-19-539561-7) Softcover, Oxford University Press, 2009.

by Robert Hauser, Kelly Lyons, Rajesh Pahwa, Theresa Zesiewicz, Lawrence Golbe. ISBN 9781873413685 (978-1-873413-68-5) Softcover, Merit Publishing International, 2003. by Rajesh Pahwa, Kelly Lyons.

Автор: Pahwa, Rajesh; Lyons, Kelly Название: Management of Early .

2010 Серия: Clinical Medicine Язык: ENG Поставляется из: Англии .

by Theresa A. Zesiewicz, Kelly E. Lyons, . lfgang H. Oertel, Rajesh Pahwa, . wrence I. Golbe, Werner Poewe, Mark Stacy, Jen C. Moller, Elisabeth Wolf.

Management of Motor Fluctuations and Dyskinesia in Parkinson's Disease (Oxford American Pocket Notes). by Theresa A. ISBN 9781873413630 (978-1-873413-63-0) Softcover, Merit Publishing Int'l, 2006.

It has been estimated that approximately 1,000,000 persons are currently diagnosed with PD in the United States and approximately 50,000 new cases are diagnosed each year. In addition, the results of the guidelines are discussed and summarized to highlight the most consistent points throughout the guidelines and discuss the differences.

Rajesh Pahwa and Kelly Lyons. Oxford American Pocket Notes . Optimal management of Parkinson's Disease is achieved through thorough assessment of many considerations affecting each patient, and incorporation of current evidence-based treatment protocols accordingly. The Parkinson's Disease treatment paradigm is currently undergoing changes as new agents and formulations emerge. This improved paradigm promises to provide physicians and patients with more effective symptom control, and perhaps, delayed disease progression.

Rajesh Pahwa, Kelly Lyons. Be the first to ask a question about Management of Early Parkinson's Disease. It has been estimated that over 1,000,000 people in the United States are affected by PD with approximately 50,000-60,000 new cases diagnosed each year. Lists with This Book. This book is not yet featured on Listopia.

Handbook of Parkinson's Disease. Handbook of Parkinson's Disease. Rajesh Pahwa, Kelly E. Lyons, William C. Roller. Download (pdf, . 0 Mb) Donate Read. Epub FB2 mobi txt RTF. Converted file can differ from the original. If possible, download the file in its original format.

Parkinson's Disease (PD) is a progressive, neurodegenerative disorder with the cardinal symptons of bradykinesia, rigidity and tremor, as well as a postural inability in the later stages of the disease. It has been estimated that over 1,000,000 people in the United States are affected by PD with approximately 50,000-60,000 new cases diagnosed each year. The average age of PD onset is 60 years, although persons can onset much later and approximately 4-10% onset prior to the age of 40. The primary neurochemical change in PD is a loss of dopamine in the substantia niger, although it is increasingly recognized that additional neurotransmitters and brain areas are involved. The cause of PD is unknown, and there is currently no cure available. The treatment of PD can be challenging and treatment of early PD can be complex with choice of initial therapy, as well as timing the initiation of therapy. Although there are currently no treatments approved to stop or slow the progression of PD, this is an area of active research, as it is estimated that approximately 60-80% of dopamine neurons are lost by the time of diagnosis. There are several symptomatic treatments available for all stages of PD, including monoamine oxidase type B (MAO-B) inhibitors, dopamine agonists, levodopa, and less commonly, anticholinergics and amantadine. The treatment regimen in the early stage needs to be individualized based on the disease characteristics and life situation of each patient. The goal of therapy in early PD is to identify a treatment strategy to control the parkinsonian symptons, such as motor fluctuations and dyskinesia, without causing adverse events.
lind-peinture.fr
© All right reserved. 2017-2020
Contacts | Privacy Policy | DMCA
eBooks are provided for reference only